Past Attendee Quotes from Previous Summits:
“It was great to have the opportunity to talk at the CHI meeting. I thought the meeting was really well attended and also had a great range on speakers on key topics.”
Staff Scientist, BioAnalytical Sciences, Genentech, Inc.
“As always, it was a fantastic event with respect to both the content and the networking opportunities.”
Associate Professor, Thayer School of Engineering, Dartmouth
“High quality content in different assay formats and technologies for immunogenicity assessment”
Senior Research Associate, Bioanalytical, Cliantha Research Ltd
“Multiple poster viewing sessions allowed me to get lots of feedback regarding my work”
Evan Dubiel, Post Doc, University of Sherbrooke
“Provided good overview of current problems and progress in the field.”
Scientist, Bioanalytical Sciences, ImmunGen
“Engaging and pertinent.”
Investigator, Clinical Immunology, GSK
“The Immunogenicity and Bioassay Summit covers the up-to-date research and regulatory advances on all aspects of immunogenicity. It’s a very good meeting for experts and newcomers to the field.”
Senior Director/Head, Bioanalytical and Biomarker Development, Research & Nonclinical Development, Shire
“Thanks for organizing this conference. Once again a very informative meeting.”
Staff Scientist, Bioanalytical Sciences, Regeneron, Inc.
“Interesting new data; very relevant to the field.”
Senior Scientist, Process Development, Amgen, Inc.
"The topics discussed were important, and the speakers were excellent".
Senior Director, Non-clinical Development, Versatis
“I have attended a number of immunogenicity/bioassay-related conferences, and I found CHI’s to be the most informative for me.”
Chief Scientific Officer, Selecta Biosciences
“That was a great conference and wonderful to meet so many great new colleagues.”
Scientist, Bioanalytical Sciences, Genentech, Inc.
“Congratulations again! It was one of the best-attended immunogenicity & bioassay meetings that I have been to. That certainly attests to your skill in keeping participants, speakers, and sponsors happy."
Professor, Research, University of Rhode Island
“Nice meeting; good mix of assays, technologies and experimental science.”
Senior Scientist, Biomarin
“It was a pleasure being at the conference: very high quality!”
Senior Expert, Immunogenicity and Bioanalysis, TNA, a Netherlands Applied Research Center
“Great event to interact with KOIs from industry and FDA to educate and re-educate yourself on aspects of immunogenicity of biologicals in the preclinical to clinical phases of drug development”
Director, Complex Generics, Momenta Pharmaceuticals
“Very informative and thought provoking meeting; high quality presentations; As a newcomer to the field, I found this conference to be an excellent resource to help me better develop strategies for advancing novel protein therapeutics.”
Team Lead, Immunology Translational Medicine, Janssen R&D, LLC
“Well organized conference with great scientific presentations and meeting content.”
Senior Principal Scientist, Drug Safety R&D, Pfizer, Inc.
“Program and participants, first class.”
Associate Director, Novo Nordisk
“Break-out interaction with FDA experts was very valuable.”
Associate Director, Alexion Pharmaceuticals Inc.
“Congratulations on a very well put together conference.”
Assistant Vice President, Pfizer